Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5382_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
17 Мб
Скачать
☆
S8/sand
400
°C
70 oC, 2 min
11
Mo-Fe-O
(a)
(b)
H
C]CO
or Ag or XeF
LiAlH
1.
2
2.
4
11
H
O
2
[
C]CH
OH[
3
2
or enzyme
H H
Figure 7.9 Radio
synthesis of
O

[
C]formaldehyde.
*
11
[
C]CH3I
Me3NO
DMF
O
11
H
NMe
C
3
3
O
H
*
 
The production of [11C]CS2 was rst reported in 1984 by Niisawa and co-workers via microwave discharge of [
11
C]CO2 in hydrogen sulde gas[96]; however, [11C]CS2 did not receive further attention until Miller etal. reported new methods (Figure7.10) for its production from [ phase reaction of [ malodourous P ing for the rapid, quantitative formation of [
11
C]CH3I in 2012[97]. In their rst report, [11C]CS2 was generated by gas-
11
C]CH3I with P2S5 at 400 °C. An improved method in which the toxic and
was replaced with elemental sulfur was subsequently reported, allow-
2S5
11
C]CS2 at 500 °C[98].
 
11
7.2.2.9.1 [
The CF3 group is present in many pharmaceuticals; however, existing radiolabelling approaches using uorine-18 suer from poor molar activities, leading Haskali and Pike to develop a novel carbon-11 radiolabelling approach using high molar activity
11
[
C]uoroform ([11C]CF3H)[99]. In this process, [11C]CF3H can be produced in 53% RCY by passing [ oric acid side product is removed from the gas stream using an in-line MeCN/dry ice trap, allowing [ (Figure7.11b).
C]Fluoroform
11
C]CH4 through a column containing CoF3 at 270 °C (Figure7.11a). The hydrou-
11
C]CF3H to be collected in chilled ethanol or N,N-dimethylformamide (DMF )
Figure 7.10 Radio
2
synthesis of

[

2
[
11
C]CH
11
[
11
[
C]CS
C]CS
°C
500
I
3
P
/sand
2S5
 155
trap
(a)
(b)
trap
or DMF
oolant
11
11
from cyclotron
trap
[
C]CH
CoF
3
4
[11C]CF3H
Pressure regulator
CH4 in N2-10% H
Liq. ArLiq. Ar
2
Guard
He
supply
Removable
11
CH4 trap
To
waste
Porapak
Q trap
Furnace (270 °C)
P
2O5
CoF
3
MeCN-
dry ice
(≈ 41 °C)
HF
11
CHF
EtOH
C
3
Figure 7.11 C]CHF3 from [C]CH4 and CoF3

7.2.2.9.2 [11C]Nitromethane
The solution-phase synthesis of [11C]nitromethane ([11C]CH3NO2) was rst reported by Schoeps etal.[100] in 1988 via reaction of [ phase process using a AgNO
column at 80 °C, as shown in Figure7.12a[101]. The reaction
2
is fast and typically uses an additional NaHCO outlet to help remove nitrogen oxide by-products of pyrolysis. Longer-chain iodides could also be converted to the respective nitro species in 50–70% RCY (based on
11
C-alkyl iodide).
11
C]CH3I with AgNO2, and a year later as a gas-
column, which is attached to the AgNO2
3
11
C-alkyl
7.2.2.9.3 [11C]Diazomethane
In 1986, Crouzel etal. reported the radiosynthesis of [11C]diazomethane ([11C]CH2N2) in a two-step process from [ partial chlorination at 310 °C, giving rise to [ of hydrazine and KOH in ethanol. [ of up to 130 GBq· μmol
7.2.2.9.4 [11C]Methyl Azide
[11C]Methyl azide ([11C]CH3N3) can be formed in one step from [11C]CH3I, as shown in Figure7.12c, providing the opportunity to perform Huisgen cycloaddition reactions with alkynes to form Schirrmacher etal. in 2008 through reaction of [ ing the 18-crown-6 cryptand[103] and was later performed on a cartridge containing
+
Na
/15-crown-5/N
156 Handbook of Radiopharmaceuticals
−1
11
C-labelled 1,2,3-triazoles. [11C]CH3N3 synthesis was rst reported by
−
in acetonitrile[104].
3
11
C]CH4 (Figure7.12b)[102]. In the rst step, [11C]CH4 undergoes
11
C]CHCl3, which is then delivered to a solution
11
C]CH2N2 was obtained in 30% RCY and molar activities
.
11
C]CH3I with NaN3 in a solution contain-
*
2
(a)
(b)
(c)
(d)
(e)
R I
80
2
°C
*
R NO
2
AgNO
R = H, alkyl
11
[
11
[
C]CH3I
11
[
11/12
[
C]CH
C]CO
C]CO
CuCl
Cl
,
2
2
11
[
4
310 °C
,
cryptand.
NaN
3
N
2
Li
SiMe
3
– N
2
barium,
2
– H2O
C]CHCl
11
CH
O
*
•
Li
SiMe
o
H
900
C
,
2
NH2NH
3
N N N
3
3
11
H H
KOH
,
2
EtOH, 60 °C
Me
Si
3
C
*
11
[
C]CH
OLi
7.2.2.9.5 [11C]Ynolates
Ynolates are triple-bond analogues of enolates, which may be promising reagents for ketenylation reactions in radiotracer synthesis. The synthesis of lithium [ ynolate (Figure7.12d) has been reported by reaction of [
11
C]CO with in situ-prepared lithi-
ated silyldiazomethane[105].
11
C]trimethylsilyl
Figure 7.12 Radio
syntheses of secondary precursors.





C]diazometh

N
2


[
C]trimeth



C]acetylene.

C]methyl
7.2.2.9.6 [11C]Acetylene
Acetylene is a useful reagent in organic synthesis; however, its complex synthesis with
11
C has limited its use a radiolabelling reagent. In 2005, Nazih etal.[106] reported a sim­plied synthetic procedure based on the method described by Madsen etal.[107]. In this process, [ tube and then heated to 900 °C under hydrogen ow to produce [ RCY and with molar activities of up to 6 GBq· μmol
 
11/12
C]CO2 is trapped at room temperature on barium within a quartz reaction
11
C]acetylene in 50–75%
−1
(Figure7.12e).

 
Early 11C-methylation reactions involved trapping the labelling agent in a solution con­taining the precursor within a small reaction vial. This technique remains widely used and
 157
is regularly incorporated into automated processes. Since this method involves multiple time-consuming transfers of reagents to and from the reactor, intermediate vials, and the purication system, it is susceptible to incomplete transfer of materials and hence diminished RCYs.
Eorts to streamline these processes led to the development of reactions that take place on an inert solid support, known as “on-cartridge” reactions. Three variations of such on-cartridge reactions have been described. First, the precursors for radiolabelling may be loaded onto an inert solid support, such as polymer resins[108, 109], silica[110],
C
-modied silica[111], or stainless steel powder[112]. After loading with precursor,
18
a small volume of solvent, gaseous [ owed over the solid support, where the reaction then takes place. Second, [
11
[
C]CH3OTf can be trapped on the solid support and a solution of the precursor owed
over the trapped
11
C-methylating agent. Third, the precursor may be covalently attached
11
C]CH3I or [11C]CH3OTf in N2 carrier gas, is gently
11
C]CH3I or
to a solid support, which is then released after reaction with the labelling agent[113]. This strategy is attractive as unreacted precursor remains resin bound, and purication
11
of the
C-labelled product is greatly simplied. For all methods, once the reaction is complete, the entire reaction mixture can be eluted into the purication system to iso­late the
11
C-labelled product.
The principal advantage of using the on-cartridge method lies in the speed with
11
which minimized, as are losses of the volatile
C radiopharmaceuticals can be produced. Transfers of the reaction mixture are
11
C-methylating agents into the headspace of the reactor, all contributing to improving both RCY and molar activities, whilst being amenable for transfer into a simple “kit” form[114]. The on-cartridge method has been used for the synthesis of a number of radiopharmaceuticals, including [ nate[115], [methyl-
11
[
C]Pittsburgh compound B ([11C]PIB)[114].
11
C]-l-methionine[116, 117], [N-methyl-11C]choline[116, 118, 119], and
11
C]methyl jasmo-
 
Wilson etal.[17, 120, 121] described the “loop” method for radiosynthesis, where the pre­cursor in a suitable solvent was coated as a thin lm onto the inner surface of a high-per­formance liquid chromatography (HPLC) loop connected directly to an HPLC purication system. [ the thin solvent lm, where it underwent rapid reaction with the precursor. The reaction mixture could then be directly eluted onto the HPLC system for purication. At the same time, Iwata etal.[122, 123] described a similar procedure using a dedicated polytetra­uoroethane (PTFE) loop. The large surface area presented by the thin lm of precursor/ solvent on the inner surface of the loop ensures ecient trapping of the labelling agent, while the resultant high concentration of precursor in the lm ensures a rapid reaction even in the absence of heating.
be easily incorporated into existing commercial synthesis systems (Figure7.13)[50, 124, 125] or used with cheaper dedicated automated systems[126, 127]. The use of EtOH as
158 Handbook of Radiopharmaceuticals
11
C]CH3I was then passed through the loop in a stream of inert gas and trapped in
The loop method is particularly attractive due to its operational simplicity, and it can
11
CH3I
HPLC LOOP
(g)
2
1
3
6
4
5
GammaDet.
N2 PRESSURE
HPLC Pump
load
inject
VIAL
iso.
NaCl
V7 V8
VIAL8VIAL
7
EtOH H2O
V9
Figure 7.13 Mod
  
“loop” synthesis.
  
9

John Wiley & Sons.
V17
C18
V22
VENT. V22/21
UV Detector
Auto Zero
UV lamp
WASTE
TO FINAL
V18
V16
BOTTLE
V15
V21
DILUTION
FLASK
MIXING
FLASK
on
N
2
off
PRODUCT
a solvent for both trapping and purication has made the process practically simpler by eliminating the reformulation step[128]. A number of radiotracers, including [ raclopride, [ nitrile ([
11
[
C]methylphenidate[132], and [11C]metomidate[133], have all been prepared using the
11
C]rolipram, [11C]3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzo-
11
C]DASB), [11C]PIB[129], [methyl-11C]-l-methionine[130], [11C]carfentanil[131],
11
C]
loop method, in generally greater RCY compared with vial-based methods.
 159
 
There have been numerous eorts to adapt more PET radiosyntheses for operation using microuidic devices. The advantages include inherent compatibility with small masses and volumes of reagents, improved heat transfer, and facile automation[134–137]. The rst application in
11
C synthesis of 11C-methyl esters from carboxylic acids was accom­plished in 65% RCY using a 0.2 μl T-shaped microreactor. The precursor and a base in DMF (5 mM) were infused by syringe pump though one arm of the T, and [ though the other arm[138]. Similarly, [
11
C]DASB[139] and [11C]raclopride[140, 141] were
11
C]CH3I was infused
prepared using microuidic methods.
  
The time taken to purify and perform quality control of the resultant 11C radiopharmaceu­tical contributes to the total synthesis time, and time savings at these steps can lead to signicant improvements in RCY and molar activity of the nal product[142].
Solid-phase extraction (SPE) has proven useful for radiotracers such as
[N-methyl-
11
([
C]β-CFT), where large dierences in polarity between the precursor and the
11
C-labelled product exist[143]. Owing to the large dierence in the amount of precursor and radiolabelled product (mg vs. μg), the precursor peak often tails into the product peak using conventional reverse-phase HPLC. To circumvent this problem, modied reverse-phase HPLC stationary phases[144] or hydrophilic interaction chromatography (HILIC)[145] has been used to develop methods where the before the precursor. Such an approach has been used for the purication of [
11
[
C]FLB457, [11C]carfentanil, [11C]DASB, [11C]WAY1000635, and [11C]SCH23390.
include: (i) use of shorter columns packed with smaller particles, where analysis times can be reduced to as little as one minute[145]; (ii) use of ultra-high performance liquid chro­matography-based methods where analysis times are 2–3 minutes[146]; and (iii) use of liquid chromatography with tandem mass spectrometry methods, as reported by Shetty etal.[147], which allows for the simultaneous determination of radiopharmaceutical identity, molar activity, and half-life.
11
C]choline and 2β-carbomethoxy-3β-(4-uorophenyl) [N-methyl-11C]tropane
11
C-labelled product elutes
11
C]raclopride,
Additional improvements toward reducing the time taken for quality-control testing
  
7.4.1 Reactions with [11C]CO
CO2 is a centrosymmetric molecule with no overall dipole, rendering it a weak electro­phile with poor solubility in organic solvents. To compensate for its low reactivity, large stoichiometric excesses and/or high pressures are often employed during reactions with
160 Handbook of Radiopharmaceuticals
2
CO2; however, this is not feasible for radiolabelling experiments due to the small quan­tities of [
11
C]CO2 available. Consequently, the direct use of [11C]CO2 was initially limited to Grignard-type chemistry involving highly reactive nucleophiles. In the last decade, how­ever, new synthetic methodologies have been developed using non-nucleophilic bases as xation agents, which serve to dramatically enhance [
11
C]CO2 solubility and reactivity.
 
11
7.4.1.1.1
Grignard reagents react rapidly with [11C]CO2 and are trapped in solution through the rapid formation of the corresponding magnesium quenched or further derivatised as required using a variety of methods (Figure7.14a–d), including: (a) aqueous workup to produce the corresponding carbonyl­acid[148], e.g. [ boxylate with primary or secondary amines to produce carbonyl­can be subsequently reduced using NaBH reaction with activating agents such as thionyl chloride or phthaloyl dichloride to pro­duce carbonyl­155], are used as amines or alcohols; and (d) reduction of the carboxylate intermediate using LiAlH lowed by halogenation, to give access to 1-
11
C-alkylating reagents in subsequent reactions[64, 160].
Organolithium reagents are more reactive than Grignard reagents and can undergo double addition with [ of reaction conditions is required to avoid side reactions. For example, [ may be obtained via reaction of methyl lithium with [ (Figure7.14e)[161–163]. [ N-isopropyl groups via reductive alkylation[163] and has been used to radiolabel tracers such as [ lithium [ azole[166].
C─C Bond Formation
11
C-carboxylate species. These may be
11
C-carboxylic
11
C]acetate[149, 150] and [11C]palmitate[108, 150]; (b) heating the car-
11
C-amides[151], which
to yield 11C-labelled tertiary amines[152]; (c)
4
11
C-acid chlorides, e.g. [11C]acetyl chloride[153], [11C]propionyl chloride[154,
11
C-cycloalkanecarbonyl chlorides[156–158], and [11C]acryloyl chloride[159], which
11
C-acylating reagents to generate 11C-amides or 11C-esters via reaction with
, fol-
11
C-alkyl halides, which can then be used as
11
C]CO2 to form carbonyl-11C-ketones; however, careful control
11
C]acetone
11
C]CO2, followed by hydrolysis
11
C]Acetone is a useful building block for the introduction of
11
C]practolol[164] and [11C]pindolol[165]. 11C-Carboxylation of tBuLi produces
11
C]pivalate, which has been used to radiolabel a tBu-substituted benzimid-
4
7.4.1.1.2 11C─H Bond Formation
11
C─H bond formation can be achieved by reaction of metal hydrides with [11C]CO2:
LiAlH
gives rise to [11C]methanol (Figure7.15a), which forms the basis of the wet method
4
11
for [
C]methyl iodide production[16] (see Section 7.2.2.2.1). LiEt3BH partially reduces
11
[
C]CO2 to give lithium [11C]formate, which can then be alkylated, providing 11C-formate esters (Figure7.15b)[29]. These can be used as by the synthesis of [
11
C]benzimidazole[167].
11
C-formylating reagents, as exemplied
 161
C]formate esters
[
O
+
1
(e)
(a)
O, H
H
2
R
OH
*
R MgX
CH
3
R
R
R I
O
R
N
*
1
R
O
Cl
*
*
2
X = R2N or O
R
NaBH
R1XH
1
R2NH
4
O
3
*
R1R2NH
heat
thionyl chloride/
[
11
C]CO
(b)
2
O
R
OMgX
*
(c)
phthaloyl chloride
(d)
(i) LiAlH
4
(ii) H2O, HI
11
[
C]CO
Li
2
LiO
H
C CH
3
*
OLi
3
+
H
H
O,
2
H
C CH
3
*
R N
O
R
*
*
R
R
2
R
1
R
X
R
2
N R
1
[11C]acetone
O
OH
*
O
N
N
N
N
*
O
HO
N
*
O
NH
OH
H
O
N
*
11
C]palmitic acid
[
via path A
20–40% RCY
11
C]WAY100635
[
via path C
2.3% RCY
133 GBq/µmol
11
(+)-[
C]PHNO
via path C
16% RCY
84 GBq/µmol
Figure 7.14 Reactions of [2 with organometallic reagents.
Figure 7.15
Reaction of

[
2 with metal
(a)
LiAlH
4
H
*
OAlH
H
H
hydride reagents.
11
C]CO
2
(b)
LiEt3BH
O
H
OLi
*
162 Handbook of Radiopharmaceuticals
3
H
ROH, H
11
[
C]pindolol
via path E
18% RCY
22–37 GBq/µmol
O
2
[11C]methanol
SO
4
2
11
[
H
*
OH
H
H
O
R
H
O
*
7.4.1.1.3 11C─N Bond Formation
Deprotonated amine bases can react directly with [11C]CO2 at room temperature, as demonstrated by Chakraborty etal. in their synthesis of [carbonyl­bis(trimethylsilyl)amide (LiHMDS) (Figure7.16a)[168]. This reaction proceeds via a
11
C-carbodiimide intermediate, which is subsequently hydrolysed to produce [11C]urea;
however, the scope of this methodology cannot be extended to the formation of substi-
11
tuted
C-ureas.
Van Tilberg etal. showed the viability of the aza-Wittig reaction for using commercially available phenyl triphenylphosphinimine[169]. Quantitative [ CO
trapping was observed at −60 °C, and the resultant phenyl [11C]isocyanate under-
2
went reaction with various amines to produce unsymmetrical carbonyl­isolated RCYs of 8–49% (Figure7.16b). In 2018, Del Vecchio etal. used this methodology to form cyclic carbonyl-
11
C-ureas in 25–85% non-isolated RCY from in situ generated phos­phinimines, synthesised by reaction of o -azidoanilines with dimethylphenylphosphine (Figure7.16c)[170]. A variety of aliphatic unsymmetrical maceutically active 34–48% and molar activities of 32–75 GBq· μmol
The ability of silylated amines to react with [ has been exploited for the method developed by Ram etal., [
11
C-ureas were labelled using this procedure, with isolated RCYs of
−1
.
11
C]CO2 to give carbonyl-11-carbamic acids
11
C-methylation as an alternative to [11C]CH3I/CH3OTf labelling. In
11
C]CO2 is delivered at −80 °C to a solution of tri-
11
C-ureas as well as ve phar-
methylsilyl amine, heated to form an O -silylcarbamate, and then reduced using LiAlH produce the corresponding approach has been used to synthesise radiotracers [ zine[172], and [
Direct one-pot
11
C]tamoxifen[174].
11
C-methylation of aliphatic and aromatic amines using [11C]CO2 has also
11
C-methylated tertiary amine (Figure7.16d)[171–174]. This
11
C]imipramine[171], [11C]chlorproma-
been achieved using phenylsilane as a reductant in the presence of a zinc-N-heterocyclic carbene complex (Figure7.16e)[175]. In this process, [
11
C]CO2 is delivered at 0 °C to a diglyme solution containing the reducing reagents and heated at 150 °C for 20 minutes to yield
11
C-methylated amines in 24–75% RCY. The amyloid-β imaging agent [11C]PIB was
radiolabelled under these conditions, but with lower molar activity than that obtained via
11
[
C]CH3OTf labelling (15 GBq· μmol−1 vs. 50 GBq· μmol−1, respectively).
11
C]urea using lithium
11
C-carboxylations
11
C]
11
C-ureas in non-
4
to
 
In 1999, Coenen etal. reported that in the presence of a tertiary amine base, non­activated amines such as aniline could react with [ carbonyl­Subsequent treatment of the gave symmetrical improve [ phinimine
11
C-carbamate salts, albeit using low-temperature trapping (Figure7.17a)[176].
11
C-carbamate with POCl3 and reaction with excess amine
11
C-ureas via an intermediate 11C-isocyanate. The use of amines to
11
C]CO2 capture was also observed by van Tilburg etal. in their study on phos-
11
C-carboxylation (vide supra)[169].
These ndings, as well as advances in “green” CO
work for what is arguably the most signicant breakthrough in
11
C]CO2 to form the corresponding
capture chemistry, laid the ground-
2
11
C chemistry since the
 163
(a)
TMS
Li
N
TMS
–5
o
11
[
C]CO
C – 25 oC
2
TMS
TMS
N
*
C
N
NH4Cl, H2O
o
25
C – 65 oC
O
H2N NH
*
2
(b)
(c)
(d)
(e)
1
R
R
N
X
PMe2Ph
N
NHR
TMS
N
2
R
1
H
N
2
R
3
PR′
H
11
[
C]CO
3
RNH
–60
2
2
o
C
*
N
C
O
X
RNH2, X = H
60 oC
X = NHR
o
C – 90 oC
20
11
[
–80
11
[
C]CO
o
C
C]CO
0 oC
2
2
O
1
R
N
OTMS
*
2
R
O
1
R
−
N
O
*
2
R
PhSiH
150 oC
i
LiAlH
Pr
60
3
ZnCl
,
Pr
i
4
o
C
2
R
R
1
N
R
1
N H
R
H
N
N
*
R
O
H N
*
O
N
R
*
CH
3
2
O
*
2
*
1
R
CH
3
N
2
R
NN
iPr
iPr
O
O
N
N
*
H
H
tryptamine-containing urea
via path B
45% RCY
(non-isolated)
N H
O
NHN
*
[11C]oxatomide
75 GBq/µmol
N
via path C
45% RCY
N
Ph
Ph
Figure 7.16 Reactions of activated amines with [2.
advent of [11C]CH3I in the 1970s–the use of strong non-nucleophilic bases as [11C]CO2 xa­tion agents to promote
11
C-carboxylation reactions with less reactive substrates. This was
rst described by Hooker etal. using the amidine base 1,8-diazabicyclo[5.4.0]undec-7-ene
164 Handbook of Radiopharmaceuticals
Ph
Ph
[11C]tamoxifen
via path D
65–84% RCY
9–15 GBq/µmol
O
*
N
HO
S
*
NH
N
[11C]PiB
via path E
38% RCY
15 GBq/µmol